Project Start
Project End
Budget Start
Budget End
Support Year
19
Fiscal Year
1996
Total Cost
Indirect Cost
Ward, M M; Marx, A S; Barry, N N (2002) Psychological distress and changes in the activity of systemic lupus erythematosus. Rheumatology (Oxford) 41:184-8
Lubeck, D P (2001) A review of the direct costs of rheumatoid arthritis: managed care versus fee-for-service settings. Pharmacoeconomics 19:811-8
Ward, M M; Marx, A S; Barry, N N (2000) Identification of clinically important changes in health status using receiver operating characteristic curves. J Clin Epidemiol 53:279-84
Ward, M M; Marx, A S; Barry, N N (2000) The rating scale preference measure as an evaluative measure in systemic lupus erythematosus. Lupus 9:696-701
Ward, M M; Marx, A S; Barry, N N (2000) Comparison of the validity and sensitivity to change of 5 activity indices in systemic lupus erythematosus. J Rheumatol 27:664-70
van Vollenhoven, R F; Park, J L; Genovese, M C et al. (1999) A double-blind, placebo-controlled, clinical trial of dehydroepiandrosterone in severe systemic lupus erythematosus. Lupus 8:181-7
Calkins, H; Yong, P; Miller, J M et al. (1999) Catheter ablation of accessory pathways, atrioventricular nodal reentrant tachycardia, and the atrioventricular junction: final results of a prospective, multicenter clinical trial. The Atakr Multicenter Investigators Group. Circulation 99:262-70
Fischer, D; Stewart, A L; Bloch, D A et al. (1999) Capturing the patient's view of change as a clinical outcome measure. JAMA 282:1157-62
Ward, M M; Lubeck, D; Leigh, J P (1998) Longterm health outcomes of patients with rheumatoid arthritis treated in managed care and fee-for-service practice settings. J Rheumatol 25:641-9
Hsieh, F Y; Bloch, D A; Larsen, M D (1998) A simple method of sample size calculation for linear and logistic regression. Stat Med 17:1623-34

Showing the most recent 10 out of 47 publications